drugset / Trial / NCT04474405
Exploratory Evaluation of Flortaucipir Injection in Healthy Volunteers and Cognitively Impaired Subjects
Non-randomizedParallel-groupOpen-labelDiagnostic
Summary
This early phase 1 study explored the brain uptake, retention, and safety of flortaucipir and obtained preliminary information regarding dosimetry of flortaucipir.
Timeline
- Start
- 2013-08-16
- Primary completion
- 2013-12-09
- Completion
- 2013-12-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Flortaucipir F18 | Diagnostic / imaging agent | 370 mbq | Intravenous |
| Background | florbetapir F 18 | Diagnostic / imaging agent | 370 mbq | Intravenous |